An Engineered Prussian Blue Nanoparticles‐Based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH‐MYCN Neuroblastoma Model

by Anshi Shukla, Juliana Cano-Mejia, Jaclyn Andricovich, Rachel A. Burga, Elizabeth E. Sweeney, Rohan Fernandes
Published 2021-08-01

348 TIL engineered with membrane-bound IL15 (cytoTIL15™) are enriched for tumor-associated antigen reactivity and demonstrate pharmacologically tunable expansion and persistence in...

by Kyle Pedro, Alonso Villasmil Ocando, Benjamin Primack, Meghan Langley, Theresa Ross, Jeremy Tchaicha, Michelle Ols, Jan ter Meulen, Violet Young, Gauri Kulkarni, Arman Aksoy, Rachel A Burga
Published 2023-11-01

Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer

by Shabnum Patel, Rachel A. Burga, Allison B. Powell, Elizabeth A. Chorvinsky, Nia Hoq, Sarah E. McCormack, Stacey N. Van Pelt, Patrick J. Hanley, Conrad Russell Y. Cruz, Conrad Russell Y. Cruz
Published 2019-04-01

Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization

by Allison B. Powell, Sridevi Yadavilli, Devin Saunders, Stacey Van Pelt, Elizabeth Chorvinsky, Rachel A. Burga, Shuroug Albihani, Patrick J. Hanley, Zhenhua Xu, Yanxin Pei, Eric S. Yvon, Eugene I. Hwang, Catherine M. Bollard, Javad Nazarian, Conrad Russell Y. Cruz
Published 2019-09-01

Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor

by Katz, Steven C, Burga, Rachel A, Naheed, Seema, Licata, Lauren A, Thorn, Mitchell, Osgood, Doreen, Nguyen, Cang T, Espat, N Joseph, Fletcher, Jonathan A., Junghans, Richard P
Published 2013